Besponsa

Made by

• Pfizer

Active Ingredient

Inotuzumab ozogamicin (genetical recombination)

Prospectus

Approval date

2018/1/19

Treats

• B-cell acute lymphoblastic leukemia, B-cell acute lymphocytic leukemia
• T-cell acute lymphoblastic leukemia, T-cell acute lymphocytic leukemia

Dosages

• BESPONSA Injection 1mg - 1331297円／瓶